메뉴 건너뛰기




Volumn 17, Issue 4, 2001, Pages 283-290

A phase II trial testing the thermal dose parameter CEM43°T90 as a predictor of response in soft tissue sarcomas treated with pre-operative thermoradiotherapy

Author keywords

Complete response; Hyperthermia; Metastasis; Radiation therapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER GRADING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SIZE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVALUATION; FEMALE; HISTOLOGY; HUMAN; HYPERTHERMIC THERAPY; MALE; MEGAVOLTAGE RADIOTHERAPY; METASTASIS; PARAMETER; PEROPERATIVE CARE; PREDICTION; PROSPECTIVE STUDY; RADIATION BEAM; RADIATION DOSE FRACTIONATION; SOFT TISSUE SARCOMA; TEMPERATURE MEASUREMENT; THERMOMETRY; TIME; TOXICITY TESTING; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0034944237     PISSN: 02656736     EISSN: None     Source Type: Journal    
DOI: 10.1080/02656730110039449     Document Type: Article
Times cited : (47)

References (21)
  • 6
    • 0021161729 scopus 로고
    • The utility of thermal dose as a predictor of tumor and normal tissue responses to combined radiation and hyperthermia
    • (1984) Cancer Res , vol.44 , Issue.10 SUPPL
    • Dewhirst, M.W.1    Sim, D.A.2
  • 12
    • 0028785043 scopus 로고
    • Thermal treatment parameters are most predictive of outcome in patients with single tumor nodules per treatment field in recurrent adenocarcinoma of the breast
    • [see comments]
    • (1995) Int J Radiat Oncol Biol Phys , vol.33 , pp. 887-899
    • Kapp, D.S.1    Cox, R.S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.